{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:40:57Z","timestamp":1778820057344,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.neuropharm.2008.05.003","type":"journal-article","created":{"date-parts":[[2008,5,10]],"date-time":"2008-05-10T09:07:20Z","timestamp":1210410440000},"page":"154-165","source":"Crossref","is-referenced-by-count":52,"title":["MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: A novel dual-acting \u03bc- and \u03ba-opioid agonist with potent antinociceptive and weak rewarding effects in mice"],"prefix":"10.1016","volume":"55","author":[{"given":"Kenjiro","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Narita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumphan","family":"Wongseripipatana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Misawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Kitajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimihito","family":"Tashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syunji","family":"Horie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2008.05.003_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000138779","article-title":"Kappa-opiate agonist-induced inhibition of gastrointestinal transit in different strains of mice","volume":"42","author":"Bansinath","year":"1991","journal-title":"Pharmacology"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib2","series-title":"A Dictionary of the Economic Products of the Malay Peninsula. Vol. II","author":"Burkill","year":"1935"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib3","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between inhibition constant (KI) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib4","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1038\/sj.bjp.0706435","article-title":"75years of opioid research: the exciting but vain quest for the Holy Grail","volume":"147","author":"Corbett","year":"2006","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib5","first-page":"74","article-title":"A method for determining loss of pain sensation","volume":"72","author":"D'Amour","year":"1941","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib6","first-page":"567","article-title":"International Union of Pharmacology. XII. Classification of opioid receptors","volume":"48","author":"Dhawan","year":"1996","journal-title":"Pharmacological Review"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0378-8741(02)00058-2","article-title":"Pseudo-akuammigine, an alkaloid from Picralima nitida seeds, has anti-inflammatory and analgesic actions in rats","volume":"81","author":"Duwiejua","year":"2002","journal-title":"Journal of Ethnopharmcology"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib8","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/0028-3908(93)90026-Y","article-title":"Blockade of morphine reward through the activation of kappa-opioid receptors in mice","volume":"32","author":"Funada","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib9","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.lfs.2004.10.038","article-title":"Antinociceptive properties of acetylenic thiophene and furan derivatives: evidence for the mechanism of action","volume":"76","author":"Goncales","year":"2005","journal-title":"Life Sciences"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1055\/s-2005-837822","article-title":"Indole alkaloids of a Thai medicinal herb, Mitragyna speciosa, that has opioid agonistic effect in guinea-pig ileum","volume":"71","author":"Horie","year":"2005","journal-title":"Planta Medica"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib11","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1124\/jpet.103.060061","article-title":"Novel 2\u2032,6\u2032-dimethyl-l-tyrosine-containing pyrazinone opioid mimetic mu-agonists with potent antinociceptive activity in mice","volume":"309","author":"Jinsmaa","year":"2004","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.neuropharm.2003.11.003","article-title":"Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors","volume":"46","author":"Khotib","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib13","first-page":"1031","article-title":"Dose- and time-dependent bimodal effects of kappa-opioid agonists on locomotor activity in mice","volume":"295","author":"Kuzmin","year":"2000","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib14","first-page":"99","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib15","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.lfs.2003.09.054","article-title":"Antinociceptive effect of 7-hydroxymitragynine in mice: discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa","volume":"74","author":"Matsumoto","year":"2004","journal-title":"Life Sciences"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.lfs.2004.10.086","article-title":"Antinociception, tolerance and withdrawal symptoms induced by 7-hydroxymitragynine, an alkaloid from the Thai medicinal herb Mitragyna speciosa","volume":"78","author":"Matsumoto","year":"2005","journal-title":"Life Sciences"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.lfs.2005.04.042","article-title":"Inhibitory effect of mitragynine, an analgesic alkaloid from Thai herbal medicine, on neurogenic contraction of the vas deferens","volume":"78","author":"Matsumoto","year":"2005","journal-title":"Life Sciences"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2006.08.013","article-title":"Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa","volume":"549","author":"Matsumoto","year":"2006","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib19","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/383819a0","article-title":"Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene","volume":"383","author":"Matthes","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.pbb.2004.12.002","article-title":"A preclinical comparison between different opioids: antinociceptive versus adverse effects","volume":"80","author":"Meert","year":"2005","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0885-3924(97)00371-0","article-title":"Comparison of the analgesic and intestinal effects of fentanyl and morphine in rats","volume":"15","author":"Megens","year":"1998","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1254\/jjp.62.15","article-title":"Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice","volume":"62","author":"Narita","year":"1993","journal-title":"Japanese Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(00)00099-1","article-title":"Regulations of opioid dependence by opioid receptor types","volume":"89","author":"Narita","year":"2001","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0306-4522(01)00151-8","article-title":"Different motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouse","volume":"105","author":"Narita","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib25","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1523\/JNEUROSCI.23-03-01006.2003","article-title":"Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion","volume":"23","author":"Narita","year":"2003","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib26","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/j.1471-4159.2005.03136.x","article-title":"Implication of cyclin-dependent kinase 5 in the development of psychological dependence on and behavioral sensitization to morphine","volume":"93","author":"Narita","year":"2005","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1021\/jm9903343","article-title":"Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists\/antagonists as potential pharmacotherapeutics for cocaine dependence","volume":"43","author":"Neumeyer","year":"2000","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2005.09.051","article-title":"Antinociceptive effect of oxycodone in diabetic mice","volume":"524","author":"Nozaki","year":"2005","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib29","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1745-7254.2006.00448.x","article-title":"Effect of GNTI, a kappa opioid receptor antagonist, on MK-801-induced hyperlocomotion and stereotypy in mice","volume":"27","author":"Qi","year":"2006","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib30","first-page":"21","article-title":"A study of kratom eaters in Thailand","volume":"27","author":"Suwanlert","year":"1975","journal-title":"Bulletin on Narcotics"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-2999(91)90774-K","article-title":"Pertussis toxin abolishes mu- and delta-opioid agonist-induced place preference","volume":"205","author":"Suzuki","year":"1991","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.brainres.2003.09.057","article-title":"Effect of repeated administration of TRK-820, a kappa-opioid receptor agonist, on tolerance to its antinociceptive and sedative actions","volume":"995","author":"Suzuki","year":"2004","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib33","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1248\/cpb.52.916","article-title":"Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa","volume":"52","author":"Takayama","year":"2004","journal-title":"Chemical and Pharmaceutical Bulletin"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib34","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1021\/jm010576e","article-title":"Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: discovery of opioid agonists structurally different from other opioid ligands","volume":"45","author":"Takayama","year":"2002","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib35","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1021\/ol062173k","article-title":"New procedure to mask the 2,3-\u03c0 bond of the indole nucleus and its application to the preparation of potent opioid receptor agonists with a Corynanthe skeleton","volume":"8","author":"Takayama","year":"2006","journal-title":"Organic Letters"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib36","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0024-3205(97)00023-4","article-title":"Inhibitory effect of mitragynine, an alkaloid with analgesic effect from Thai medicinal plant Mitragyna speciosa, on electrically stimulated contraction of isolated guinea-pig ileum through the opioid receptor","volume":"60","author":"Watanabe","year":"1997","journal-title":"Life Sciences"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib37","series-title":"Pharmacological Research on Traditional Herbal Medicines","first-page":"163","article-title":"Pharmacological properties of some structurally related indole alkaloids contained in the Asian herbal medicines, hirsutine and mitragynine, with special reference to their Ca2+ antagonistic and opioid-like effects","author":"Watanabe","year":"1999"},{"key":"10.1016\/j.neuropharm.2008.05.003_bib38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0022-3565(24)29575-6","article-title":"In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist\/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence","volume":"297","author":"Wells","year":"2001","journal-title":"Journal of Pharmacology and Experimental Therapeutics"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808001305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808001305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T05:54:55Z","timestamp":1738216495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390808001305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0028390808001305"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2008.05.003","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}